On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Amvac AG's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€217k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- MULEVACLINPartner
Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€217ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Universidad Autonoma de MadridSpain · 1 shared project
- Istituto Superiore di SanitaItaly · 1 shared project
- Instituto de Salud Carlos IiiSpain · 1 shared project
- Schweizerisches Tropen und Public Health InstitutSwitzerland · 1 shared project
- Instituto de Biologia Molecular e Celular-IbmcPortugal · 1 shared project
- Etna Biotech SRLItaly · 1 shared project
- Infectious Disease Research InstituteUnited States · 1 shared project
- Meditox S.r.oCzech Republic · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- immunology
- proteins
- public health
- tropical medicine
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗